These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 17086606)

  • 1. Ibuprofen fails to prevent brain pathology in a model of neuropsychiatric lupus.
    Ballok DA; Ma X; Denburg JA; Arsenault L; Sakic B
    J Rheumatol; 2006 Nov; 33(11):2199-213. PubMed ID: 17086606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropsychiatric Systemic Lupus Erythematosus Is Dependent on Sphingosine-1-Phosphate Signaling.
    Mike EV; Makinde HM; Der E; Stock A; Gulinello M; Gadhvi GT; Winter DR; Cuda CM; Putterman C
    Front Immunol; 2018; 9():2189. PubMed ID: 30319641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hippocampal damage in mouse and human forms of systemic autoimmune disease.
    Ballok DA; Woulfe J; Sur M; Cyr M; Sakic B
    Hippocampus; 2004; 14(5):649-61. PubMed ID: 15301441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurodegeneration in autoimmune MRL-lpr mice as revealed by Fluoro Jade B staining.
    Ballok DA; Millward JM; Sakic B
    Brain Res; 2003 Feb; 964(2):200-10. PubMed ID: 12576180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The T Cell Receptor Repertoire in Neuropsychiatric Systemic Lupus Erythematosus.
    Moore E; Huang MW; Jain S; Chalmers SA; Macian F; Putterman C
    Front Immunol; 2020; 11():1476. PubMed ID: 32765512
    [No Abstract]   [Full Text] [Related]  

  • 6. Analysis of brain metabolites by gas chromatography-mass spectrometry reveals the risk-benefit concerns of prednisone in MRL/lpr lupus mice.
    Zhou J; Lu F; Li S; Xie M; Lu H; Xie Z; Wu D; Wang S; Wen C; Xu ZH
    Inflammopharmacology; 2020 Apr; 28(2):425-435. PubMed ID: 31786803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropsychiatric disease in murine lupus is dependent on the TWEAK/Fn14 pathway.
    Wen J; Xia Y; Stock A; Michaelson JS; Burkly LC; Gulinello M; Putterman C
    J Autoimmun; 2013 Jun; 43():44-54. PubMed ID: 23578591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyruvate kinase isoform M2 impairs cognition in systemic lupus erythematosus by promoting microglial synaptic pruning via the β-catenin signaling pathway.
    Lu L; Wang H; Liu X; Tan L; Qiao X; Ni J; Sun Y; Liang J; Hou Y; Dou H
    J Neuroinflammation; 2021 Oct; 18(1):229. PubMed ID: 34645459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Centrally Acting Angiotensin-Converting Enzyme Inhibitor Suppresses Type I Interferon Responses and Decreases Inflammation in the Periphery and the CNS in Lupus-Prone Mice.
    Nocito C; Lubinsky C; Hand M; Khan S; Patel T; Seliga A; Winfield M; Zuluaga-Ramirez V; Fernandes N; Shi X; Unterwald EM; Persidsky Y; Sriram U
    Front Immunol; 2020; 11():573677. PubMed ID: 33042154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment with lysophosphatidic acid prevents microglial activation and depression-like behaviours in a murine model of neuropsychiatric systemic lupus erythematosus.
    Nagata W; Koizumi A; Nakagawa K; Takahashi S; Gotoh M; Satoh Y; Ishizuka T
    Clin Exp Immunol; 2023 Apr; 212(2):81-92. PubMed ID: 36718978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unique primed status of microglia under the systemic autoimmune condition of lupus-prone mice.
    Nomura A; Noto D; Murayama G; Chiba A; Miyake S
    Arthritis Res Ther; 2019 Dec; 21(1):303. PubMed ID: 31888754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppression prevents neuronal atrophy in lupus-prone mice: evidence for brain damage induced by autoimmune disease?
    Sakic B; Kolb B; Whishaw IQ; Gorny G; Szechtman H; Denburg JA
    J Neuroimmunol; 2000 Nov; 111(1-2):93-101. PubMed ID: 11063826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CSF-1R inhibition attenuates renal and neuropsychiatric disease in murine lupus.
    Chalmers SA; Wen J; Shum J; Doerner J; Herlitz L; Putterman C
    Clin Immunol; 2017 Dec; 185():100-108. PubMed ID: 27570219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disturbed distribution of proliferative brain cells during lupus-like disease.
    Stanojcic M; Burstyn-Cohen T; Nashi N; Lemke G; Sakic B
    Brain Behav Immun; 2009 Oct; 23(7):1003-13. PubMed ID: 19501646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ectopic CD4
    Wang K; Hou X; Lu H; Han N; Xie M; Xi A; Xu Z
    J Autoimmun; 2024 May; 145():103199. PubMed ID: 38452512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating brain-reactive autoantibodies and behavioral deficits in the MRL model of CNS lupus.
    Williams S; Sakic B; Hoffman SA
    J Neuroimmunol; 2010 Jan; 218(1-2):73-82. PubMed ID: 19919882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CXCL13 Neutralization Attenuates Neuropsychiatric Manifestations in Lupus-Prone Mice.
    Huang MW; Stock AD; Putterman C
    Front Immunol; 2021; 12():763065. PubMed ID: 34868008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limited preventive effect of prednisone on neuropsychiatric symptoms in murine systemic lupus erythematosus.
    Lu F; Lu H; Xie M; Li S; Zu Y; Zhou J; Yu J; Wang S; Ruan Y; Wen C; Xu Z
    Inflammopharmacology; 2019 Jun; 27(3):511-520. PubMed ID: 30911862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrathecal antibodies and brain damage in autoimmune MRL mice.
    Stanojcic M; Loheswaran G; Xu L; Hoffman SA; Sakic B
    Brain Behav Immun; 2010 Feb; 24(2):289-97. PubMed ID: 19853033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time course and nature of brain atrophy in the MRL mouse model of central nervous system lupus.
    Sled JG; Spring S; van Eede M; Lerch JP; Ullal S; Sakic B
    Arthritis Rheum; 2009 Jun; 60(6):1764-74. PubMed ID: 19479832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.